home / stock / toiiw / toiiw news


TOIIW News and Press, The Oncology Institute Inc. Warrant From 03/27/24

Stock Information

Company Name: The Oncology Institute Inc. Warrant
Stock Symbol: TOIIW
Market: NASDAQ
Website: theoncologyinstitute.com

Menu

TOIIW TOIIW Quote TOIIW Short TOIIW News TOIIW Articles TOIIW Message Board
Get TOIIW Alerts

News, Short Squeeze, Breakout and More Instantly...

TOIIW - The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024

CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year end...

TOIIW - MaxHealth & The Oncology Institute Expand Value-Based Care Partnership

CERRITOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology group, and MaxHealth, an innovative leader in value-based primary care, have announced a comprehensive new agreement. Under this full-risk arrangement, TOI will assume c...

TOIIW - The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

CERRITOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its fourth quarter and full year 2023 financial results after th...

TOIIW - Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model

SAN FRANCISCO and LAS VEGAS, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Today, The Oncology Institute (TOI), one of the largest value-based oncology practices in the country, announced its partnership with Carrum Health. This collaboration aims to provide high-quality, cost-effective breast cancer care to...

TOIIW - WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio

CERRITOS, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- WellBe Senior Medical announced today that it is strengthening its cancer care capabilities to further support its mission of managing the population health of polychronic Medicare Advantage patients by partnering with leading cancer care provid...

TOIIW - The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California

CERRITOS, Calif, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (TOI) announced today that it has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill not only critical spec...

TOIIW - The Oncology Institute, Inc. (TOI) Q3 2023 Earnings Call Transcript

2023-11-10 03:25:07 ET The Oncology Institute, Inc. (TOI) Q3 2023 Earnings Conference Call November 08, 2023, 05:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Dan Virnich - Chief Executive Officer Mihir Shah - Chief Financial Officer C...

TOIIW - The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance

CERRITOS, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three and nine months ended ...

TOIIW - The Oncology Institute Announces Third Quarter 2023 Earnings Release Date and Conference Call

CERRITOS, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2023 financial results after the market close o...

TOIIW - U.S. Physical Therapy Remains Overpriced (Rating Downgrade)

2023-10-16 13:25:25 ET Summary U.S. Physical Therapy's stock has underperformed the S&P 500 since I rated it a 'hold' in November 2022. The company's financial performance has been mixed, with a decline in net income and operating cash flow. The stock is pricey compared to...

Previous 10 Next 10